Converting Intravenous Dosing to Subcutaneous Dosing With Recombinant Human Hyaluronidase

The preferred route of administration for an injected therapeutic agent is subcutaneous (SC), but SC injections are generally limited to no more than 1-2 mL in volume, representing a major challenge, especially for large protein biologics.
Oct 02, 2007